Patient Guide: Clinical Trial of TQA3605 Tablet in Combination With Nucleos(t)Ide Analogues(NAs) Versus NAs Alone for the Treatment of Patients With Chronic Hepatitis B Virus Infection Who Have Undergone Treatment and Exhibit Low Viral Load or Poor Response

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • ✓ Get matched to the right study location for you
  • ✓ Connect directly with study coordinators at 76 participating sites
  • ✓ Understand eligibility with our simplified screening tool
  • ✓ Free service - we're here to help you access clinical research
Trial ID: NCTNCT07797231
Status: UPCOMING
Condition: Chronic Hepatitis B
Phase: Phase III

Find a Study Location Near You

This study is available at 76 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • • Hefei, Anhui
  • • Hefei, Anhui
  • • Wuhu, Anhui
  • • And 73 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily

Clinical Trial of TQA3605 Tablet in Combination With Nucleos(t)Ide Analogues(NAs) Versus NAs Alone for the Treatment of Patients With Chronic Hepatitis B Virus Infection Who Have Undergone Treatment and Exhibit Low Viral Load or Poor Response - Join Clinical Trial NCTNCT07797231

How to Join This Clinical Trial - NCTNCT07797231

Learn how to participate in this Phase III trial studying an investigational therapy for Chronic Hepatitis B. Current status: UPCOMING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Chronic Hepatitis B. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Chronic Hepatitis B
Treatment Being Tested
Investigational treatment
Study Phase
Phase III - Large-scale efficacy study
Enrollment Status
UPCOMING
Study Identifier
NCTNCT07797231 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 76 locations. Find a study site near you:

Clinical Research Site

Hefei, Anhui 230001 - China

Status: Contact for availability

Clinical Research Site

Hefei, Anhui 230001 - China

Status: Contact for availability

Clinical Research Site

Wuhu, Anhui 241001 - China

Status: Contact for availability

Clinical Research Site

Beijing, Beijing Municipality 100000 - China

Status: Contact for availability

Clinical Research Site

Beijing, Beijing Municipality 100010 - China

Status: Contact for availability

Clinical Research Site

Beijing, Beijing Municipality 100069 - China

Status: Contact for availability

Clinical Research Site

Chongqing, Chongqing Municipality 40000 - China

Status: Contact for availability

Clinical Research Site

Chongqing, Chongqing Municipality 400038 - China

Status: Contact for availability

Clinical Research Site

Chongqing, Chongqing Municipality 404000 - China

Status: Contact for availability

Clinical Research Site

Fuzhou, Fujian 350007 - China

Status: Contact for availability

And 66 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this Phase III clinical trial for Chronic Hepatitis B:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai as Your Clinical Trial Matching Service

Quri.ai is a free clinical trial matching service that helps patients connect with research sites. We make it easier to:

  • Find clinical trials that match your condition
  • Get matched to the right study location near you
  • Connect directly with study coordinators
  • Understand if you qualify with simplified eligibility screening
  • Navigate the enrollment process with personalized support
  • Access new treatments through clinical research participation